Eupraxia Pharmaceuticals Inc (EPRX) — Working Capital to Net Assets Ratio
Eupraxia Pharmaceuticals Inc (EPRX) has a Working Capital to Net Assets ratio of 99.0% as of September 2025. Working capital of CA$121.88 Million (current assets of CA$127.18 Million minus current liabilities of CA$5.30 Million) is measured against net assets of CA$123.06 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see Eupraxia Pharmaceuticals Inc (EPRX) total assets.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Eupraxia Pharmaceuticals Inc Working Capital to Net Assets (2017–2024)
This chart shows how Eupraxia Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 99.0%, reflecting working capital of CA$121.88 Million against net assets of CA$123.06 Million CAD. Explore EPRX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Eupraxia Pharmaceuticals Inc (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Eupraxia Pharmaceuticals Inc from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Eupraxia Pharmaceuticals Inc (EPRX) total liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 65.5% | CA$29.97 Million | CA$45.77 Million | CA$34.44 Million | CA$4.46 Million | ▲ +553.6 pp |
| 2023 | -488.1% | CA$-5.74 Million | CA$1.18 Million | CA$19.80 Million | CA$25.55 Million | ▼ -673.2 pp |
| 2022 | 185.1% | CA$21.03 Million | CA$11.36 Million | CA$25.18 Million | CA$4.14 Million | ▲ +40.2 pp |
| 2021 | 144.9% | CA$28.33 Million | CA$19.55 Million | CA$30.60 Million | CA$2.27 Million | ▲ +46.1 pp |
| 2020 | 98.8% | CA$-21.40 Million | CA$-21.66 Million | CA$1.14 Million | CA$22.54 Million | ▼ -0.6 pp |
| 2019 | 99.4% | CA$-18.03 Million | CA$-18.13 Million | CA$2.64 Million | CA$20.67 Million | ▼ -4.4 pp |
| 2018 | 103.8% | CA$-11.87 Million | CA$-11.44 Million | CA$2.47 Million | CA$14.34 Million | ▲ +11.9 pp |
| 2017 | 91.9% | CA$4.69 Million | CA$5.11 Million | CA$5.42 Million | CA$730.68K | — |